Post by
StockPicker88 on Apr 09, 2016 2:44pm
Tech my view
Chart does not look pretty for CXR. The stock is trending lower. This has nothing to do with fundamentals. Hedge funds over bought this stock and now they are selling on any rally. The bigger problem is that whole healthcare is over bought and are under pressure. Allergan is a prime example. The company is ok fundamentally but too many funds own the stock. Now the Pfizer deal is off. A lot of these funds have to sell. This process could take some time.
The only bright spot I see is IBB. It looks like it had a double bottom formation and broke out last week. A little pull back in the past couple sessions but that is pretty common. If this breakout is for real, it could potentially carry CXR with it. Right now there is very little buying or selling interest in CXR at this price level. Index buying could easily move it.
Next resistance is $39ish and then $47ish.
Comment by
puma1 on Apr 09, 2016 6:33pm
The IBB looks like a DB, but I don't think it will break yet. It is still too far below the 200 mda and it has to get over that first imo to signal. We are probably a choppy sideways for a while. CXR has to get closer to the end of Q2 and when it gets picked up they will be showing $1.60 plus the trend will flow.
Comment by
StockPicker88 on Apr 09, 2016 7:33pm
Good point. Like I said, individual charts still look pretty bad and that may drag on index. On the other hand, US market corrects real fast these days. There seems to be a lot of captial sitting on the side line watiing for opportunities. We will see what happens in the next few days.